Stroke and Traumatic Brain Injury are two conditions that may only happen once in your life but can have long lasting effects. Many people who have experienced either condition can suffer from partial paralysis, spasticity, dysphagia (swallowing difficulties), and other sensory issues for an extended period after the event. Here at New England Institute for Clinical Research, we are dedicated to improving the lives of those suffering from these prolonged issues.
MERZ M602011014
This study is designed to evaluate the efficacy and safety of NT 201 in individuals (18 to 85
years old) with leg spasticity due to stroke or traumatic brain injury (TBI). NT 201 works to
block the signals that tells the affected muscles to contract, thus helping to prevent the
spastic muscles from “tightening up”. The main period of the clinical trial involves one
injection cycle, where the patient either receives NT 201 (the active study drug) or placebo
for leg spasticity. The main period is followed by an open-label extension period where the
participant receives up to five injections of the definite study medication (NT 201) for
spasticity of both the leg and arm, if indicated. The duration of the study (main period and
open-label) will be at a minimum of 60 weeks to a maximum of 92 weeks.
Learn more: https://classic.clinicaltrials.gov/ct2/show/NCT03992404
All studies and study related procedures are provided at no cost to you. There may be compensation to you for your time and travel. Participation is completely voluntary, meaning that you can withdraw at any time. If you are interested, please fill out the form below or give us a call at 203-914-1903.